Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AmberNoon is a healthcare-focused apparel company founded by board-certified dermatologist Dr. Erum Ilyas. The company specializes in the development and commercialization of sun-protective clothing designed to provide a physical barrier against harmful UV radiation. Each garment is engineered with a UPF 50+ rating, aiming to reduce the risk of skin cancer, melanoma, and premature skin aging. AmberNoon distinguishes itself by blending medical-grade protection with contemporary fashion, encouraging consistent daily use among consumers. The brand serves as a preventative health tool within the dermatology and wellness sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AmberNoon.